Patents by Inventor Eiji Nishiyama
Eiji Nishiyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11334727Abstract: A technology is for writing different information depending on an object into an electronic tag. The above problem is solved by an electronic tag writing system including a writing device that writes write information into an electronic tag, and an information acquisition section that acquires write information related to an object associated with the electronic tag, in which the write information acquired by the information acquisition section is written into the electronic tag using the writing device.Type: GrantFiled: April 19, 2019Date of Patent: May 17, 2022Assignees: Daio Paper Corporation, Daio Engineering Co., Ltd.Inventors: Taro Ikawa, Koki Beppu, Hirohide Ouchi, Eiji Nishiyama, Ryoto Takahashi, Shin Koyama, Shuntaro Noguchi
-
Publication number: 20210081621Abstract: A technology is for writing different information depending on an object into an electronic tag. The above problem is solved by an electronic tag writing system including a writing device that writes write information into an electronic tag, and an information acquisition section that acquires write information related to an object associated with the electronic tag, in which the write information acquired by the information acquisition section is written into the electronic tag using the writing device.Type: ApplicationFiled: April 19, 2019Publication date: March 18, 2021Applicants: Daio Paper Corporation, Daio Engineering Co., Ltd.Inventors: Taro Ikawa, Koki Beppu, Hirohide Ouchi, Eiji Nishiyama, Ryoto Takahashi, Shin Koyama, Shuntaro Noguchi
-
Publication number: 20100137228Abstract: Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1): foods, drinks, cosmetics, etc. containing as the active ingredient at least one member selected from the group consisting of the above-mentioned compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. This compound also shows, for example, an apoptosis-inducing activity, a carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes it useful also as the active ingredient of antioxidants and preservatives.Type: ApplicationFiled: August 11, 2008Publication date: June 3, 2010Applicant: TAKARA BIO INC.Inventors: Tatsuji ENOKI, Hiroaki SAGAWA, Takanari TOMINAGA, Eiji NISHIYAMA, Nobuto KOYAMA, Takeshi SAKAI, Fu-Gong YU, Katsushige IKAI, Ikunoshin KATO
-
Patent number: 7678368Abstract: To find a substance which has a skin cosmeticizing effect such as prevention of skin aging, amelioriation of sensitive skin, or antipruritic action, and can serve as an effective ingredient for a hair-care product, thereby providing cosmetics comprising the effective ingredient. Concretely, there are provided cosmetics characterized in that the cosmetics comprise as an effective ingredient a compound selected from a fucoidan, a degradation product thereof, a sulfated monosaccharide or a salt thereof.Type: GrantFiled: December 20, 2005Date of Patent: March 16, 2010Assignee: Takara Bio Inc.Inventors: Shigetoshi Mizutani, Suzu Deguchi, Eiji Kobayashi, Eiji Nishiyama, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20100048491Abstract: Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1): foods, drinks, cosmetics, etc. containing as the active ingredient at least one member selected from the group consisting of the above-mentioned compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. This compound also shows, for example, an apoptosis-inducing activity, a carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes it useful also as the active ingredient of antioxidants and preservatives.Type: ApplicationFiled: August 11, 2008Publication date: February 25, 2010Applicant: TAKARA BIO INC.Inventors: Tatsuji ENOKI, Hiroaki SAGAWA, Takanari TOMINAGA, Eiji NISHIYAMA, Nobuto KOYAMA, Takeshi SAKAI, Fu-Gong YU, Katsushige IKAI, Ikunoshin KATO
-
Publication number: 20090099101Abstract: Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1): foods, drinks, cosmetics, etc. containing as the active ingredient at least one member selected from the group consisting of the above-mentioned compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. This compound also shows, for example, an apoptosis-inducing activity, a carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes it useful also as the active ingredient of antioxidants and preservatives.Type: ApplicationFiled: August 11, 2008Publication date: April 16, 2009Applicant: Takara Shuzo Co., Ltd.Inventors: Tatsuji Enoki, Hiroaki Sagawa, Takanari Tominaga, Eiji Nishiyama, Nobuto Koyama, Takeshi Sakai, Fu-Gong Yu, Katsushige Ikai, Ikunoshin Kato
-
Patent number: 7417031Abstract: Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1): foods, drinks, cosmetics, etc. containing as the active ingredient at least one member selected from the group consisting of the above-mentioned compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. This compound also shows, for example, an apoptosis-inducing activity, a carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes it useful also as the active ingredient of antioxidants and preservatives.Type: GrantFiled: January 13, 2005Date of Patent: August 26, 2008Assignee: Takara Bio Inc.Inventors: Tatsui Enoki, Hiroaki Sagawa, Takanari Tominaga, Eiji Nishiyama, Nobuto Koyama, Takeshi Sakai, Fu-Gong Yu, Katsushige Ikai, Ikunoshin Kato
-
Patent number: 7268160Abstract: The present invention provides a therapeutic agent or prophylactic agent for a disease that requires enhancement of nerve growth factor production, an enhancer for nerve growth factor production, or a food, beverage or feed for enhancing nerve growth factor production, each comprising as an effective ingredient a specified compound or a salt thereof having enhancing activity for nerve growth factor production; a method for enhancing nerve growth factor production, comprising administering to a mammal the above-mentioned compound or a salt thereof; and use of the above-mentioned compound or a salt thereof in the preparation of a therapeutic agent or prophylactic agent for a disease that requires enhancement of nerve growth factor production, an enhancer for nerve growth factor production, or a food, beverage or feed for enhancing nerve growth factor production. In addition, the present invention provides novel compounds having enhancing activity for nerve growth factor production.Type: GrantFiled: January 26, 2001Date of Patent: September 11, 2007Assignee: Takara Bio, Inc.Inventors: Hiromu Ohnogi, Masahiro Shiraga, Eiji Kobayashi, Tuo-Ping Li, Suzu Deguchi, Eiji Nishiyama, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20060093566Abstract: To find a substance which has a skin cosmeticizing effect such as prevention of skin aging, amelioriation of sensitive skin, or antipruritic action, and can serve as an effective ingredient for a hair-care product, thereby providing cosmetics comprising the effective ingredient. Concretely, there are provided cosmetics characterized in that the cosmetics comprise as an effective ingredient a compound selected from a fucoidan, a degradation product thereof, a sulfated monosaccharide or a salt thereof.Type: ApplicationFiled: December 20, 2005Publication date: May 4, 2006Inventors: Shigetoshi Mizutani, Suzu Deguchi, Eiji Kobayashi, Eiji Nishiyama, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20050202064Abstract: A product obtained by heating at least one substance selected from the following (a), (b) and (c). (a) uronic acid or uronic acid derivative; (b) a saccharide compound containing uronic acid or a saccharide compound containing uronic acid derivative; and (c) a substance containing a saccharide compound containing uronic acid or a substance containing a saccharide compound containing uronic acid derivative; and food, beverage or a pharmaceutical agent which is characterized in containing the above-mentioned heat-treated product.Type: ApplicationFiled: April 26, 2005Publication date: September 15, 2005Inventors: Nobuto Koyama, Hiroaki Sagawa, Eiji Kobayashi, Tatsuji Enoki, Hua-Kang Wu, Eiji Nishiyama, Suzu Deguchi, Katsushige Ikai, Hiromu Ohnogi, Motoko Ueda, Akihiro Kondo, Ikunoshin Kato
-
Patent number: 6911432Abstract: Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose are represented by formula (I): These compositions include foods, drinks, cosmetics, etc. containing as the active ingredient at least one such compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. These compounds show an apoptosis-inducing activity, carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes them useful also as the active ingredient of antioxidants and preservatives.Type: GrantFiled: August 27, 2002Date of Patent: June 28, 2005Inventors: Tatsuji Enoki, Hiroaki Sagawa, Takanari Tominaga, Eiji Nishiyama, Nobuto Koyama, Takeshi Sakai, Fu-Gong Yu, Katsushige Ikai, Ikunoshin Kato
-
Publication number: 20050124575Abstract: Remedies or preventives, which are characterized by containing as the active ingredient at least one member selected from the group consisting of agar, agarose, high-molecular weight digestion products originating in agar and high-molecular weight digestion products originating in agarose, for diseases sensitive to the above active ingredients.Type: ApplicationFiled: April 14, 2003Publication date: June 9, 2005Applicant: Takara Bio Inc.Inventors: Eiji Nishiyama, Nobuko Muraki, Hiromu Ohnogi, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20050119191Abstract: Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1): foods, drinks, cosmetics, etc. containing as the active ingredient at least one member selected from the group consisting of the above-mentioned compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. This compound also shows, for example, an apoptosis-inducing activity, a carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes it useful also as the active ingredient of antioxidants and preservatives.Type: ApplicationFiled: January 13, 2005Publication date: June 2, 2005Applicant: Takara Shuzo Co., Ltd.Inventors: Tatsui Enoki, Hiroaki Sagawa, Takanari Tominaga, Eiji Nishiyama, Nobuto Koyama, Takeshi Sakai, Fu-Gong Yu, Katsushige Ikai, Ikunoshin Kato
-
Publication number: 20040219238Abstract: According to the present invention, there is provided a medicament for oral administration or intravenous administration that is effective for a disease requiring enhancement of nerve growth factor production, comprising as an effective ingredient a pulverized product and/or extract obtained from Humulus lupulus and/or Angelica keiskei koidz., or xanthohumol and/or a pharmacologically acceptable salt thereof. The medicament is useful as a therapeutic agent or prophylactic agent for a disease requiring enhancement of nerve growth factor production, such as dementia or a nerve disorder.Type: ApplicationFiled: January 12, 2004Publication date: November 4, 2004Inventors: Eiji Nishiyama, Suzu Deguchi, Hiromu Ohnogi, Katsumi Sugiyama, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20040029828Abstract: The present invention provides an agent for maintaining homeostasis in a living body, food, beverage or feed, utilizing a fucoidan, a degradation product thereof or a salt thereof, having an action for maintaining homeostasis in a living body.Type: ApplicationFiled: March 13, 2003Publication date: February 12, 2004Inventors: Eiji Nishiyama, Hiroaki Sagawa, Fumitsugu Hino, Etsuko Morihara, Takeshi Sakai, Haruo Oyashiki, Ikunoshin Kato
-
Publication number: 20030176393Abstract: A product obtained by heating at least one substance selected from the following (a), (b) and (c).Type: ApplicationFiled: September 30, 2002Publication date: September 18, 2003Inventors: Nobuto Koyama, Hiroaki Sagawa, Eiji Kobayashi, Tatsuji Enoki, Hua-Kang Wu, Eiji Nishiyama, Suzu Deguchi, Katsushige Ikai, Hiromu Ohnogi, Motoko Ueda, Akihiro Kondo, Ikunoshin Kato
-
Patent number: 6608032Abstract: Medicinal compositions for treating or preventing diabetes, rheumatoid, diseases wherein inflammation should be inhibited, diseases wherein &agr;-glycosidase should be inhibited, diseases wherein the synthesis of prostaglandin should be inhibited, diseases wherein endotoxin shock should be inhibited, diseases wherein the production of interleukin should be inhibited, diseases wherein the production of heme oxygenase should be induced, and diseases wherein the production of tumor necrosis factor or carcinogenesis should be inhibited, which contain as the active ingredient at least one compound selected from the group consisting of 3,6-anhydrogalactopyranose represented by formula (I), its aldehyde, its hydrate and 2-O-methylated derivatives and 2-O-sulfated derivatives thereof.Type: GrantFiled: July 20, 2001Date of Patent: August 19, 2003Assignee: Takara Shuzo Co., Ltd.Inventors: Tatsuji Enoki, Hiroaki Sagawa, Jun Tomono, Takanari Tominaga, Eiji Nishiyama, Hua-Kang Wu, Ikunoshin Kato
-
Publication number: 20030144316Abstract: The present invention provides a therapeutic agent or prophylactic agent for a disease that requires enhancement of nerve growth factor production, an enhancer for nerve growth factor production, or a food, beverage or feed for enhancing nerve growth factor production, each comprising as an effective ingredient a specified compound or a salt thereof having enhancing activity for nerve growth factor production; a method for enhancing nerve growth factor production, comprising administering to a mammal the above-mentioned compound or a salt thereof; and use of the above-mentioned compound or a salt thereof in the preparation of a therapeutic agent or prophylactic agent for a disease that requires enhancement of nerve growth factor production, an enhancer for nerve growth factor production, or a food, beverage or feed for enhancing nerve growth factor production. In addition, the present invention provides novel compounds having enhancing activity for nerve growth factor production.Type: ApplicationFiled: July 26, 2002Publication date: July 31, 2003Inventors: Hiromu Ohnogi, Masahiro Shiraga, Eiji Kobayashi, Tuo-Ping Li, Suzu Deguchi, Eiji Nishiyama, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20030105029Abstract: Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose are represented by formula (I): 1Type: ApplicationFiled: August 27, 2002Publication date: June 5, 2003Applicant: TAKARA SHUZO CO., LTD.Inventors: Tatsuji Enoki, Hiroaki Sagawa, Takanari Tominaga, Eiji Nishiyama, Nobuto Koyama, Takeshi Sakai, Fu-Gong Yu, Katsushige Ikai, Ikunoshin Kato
-
Patent number: 6548543Abstract: Remedies or preventives for diseases with a need for immunoregulation, diseases with a need for inhibition of inflammation, diseases with a need for regulation of tumor necrosis factor production, diseases with a need for regulation of fungal growth, diseases with a need for regulation of cell adhesion or disease with a deed for induction of heat-shock protein, which contain as the active ingredient at least one compound selected from among cyclopentenone derivatives represented by general formula [I], optically active isomers and salts thereof, wherein R1 and R2 are the same or different and each represents hydrogen, an aliphatic group, an aromatic group or an aromatic aliphatic group.Type: GrantFiled: February 20, 2001Date of Patent: April 15, 2003Assignee: Takara Shuzo Co., Ltd.Inventors: Eiji Kobayashi, Hiromu Ohnogi, Hiroaki Sagawa, Takanari Tominaga, Eiji Nishiyama, Nobuto Koyama, Katsushige Ikai, Ikunoshin Kato